Breakthrough transcatheter aortic valve technology for aortic regurgitation and stenosis featured in front of global clinical audience during premier interventional cardiology event. ...
Pioneering next-generation sequencing technology delivers rapid, accurate pathogen identification to accelerate targeted treatment and improve patient outcomes across clinical settings....
Milestone enhances clinical use of the FARAPULSE™ Pulsed Field Ablation platform for treatment of atrial fibrillation, strengthening its role in next-generation cardiac electrophysiology....
Acquisition adds FDA-cleared Valeda® Light Delivery System to Alcon’s pipeline, targeting early and intermediate dry age-related macular degeneration through photobiomodulation technology ...
Regulatory milestone paves the way for expanded access to Morphic’s non-implant, incisionless solution for treating acid reflux and related gastrointestinal disorders across Europe....
Innovative thin-film formulation of cladribine moves forward as BioNxt prepares for next-stage development in multiple sclerosis therapy, aiming to enhance patient convenience and treatment adherence....
Enterprise Imaging Cloud Now Integrates Pathology for Streamlined Cancer Diagnostics and Cross-Disciplinary Collaboration ...
New microencapsulation technology ensures NADH stability and absorption, setting a new benchmark in cellular health and longevity supplements. ...
Ceramic-based hip resurfacing implant gains European regulatory approval, offering patients a bone-preserving, metal-free alternative for hip joint restoration....
FDA clears assay as companion diagnostic for ZEGFROVY™ and broad tumor profiling, advancing precision oncology diagnostics....
